FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

FONAR CorporationNASDAQ: FONR

Operating Expenses · Q3 FY2026 · quarter ended Mar 2026

Operating expenses grows, but more slowly than its trailing trend

Q3 FY2026 operating expenses of $8.8M rose 4.3% year over year, behind the +8.0% change in trailing-twelve-month operating expenses. Sequentially, it rose 31.4% from the prior quarter. Over 3 fiscal years it compounded at +7.8% a year.

Context

  • Operating expenses amounted to 30.0% of revenue in FY2025, up 2.2 pp from a year earlier.
  • Operating expenses increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +4.3% toward the trailing-twelve-month pace of +8.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.8M+31.4% QoQ
Last fiscal yearJun 2025
$31.31M+9.5% YoY
LTMMar 2026
$32.88M+8.0% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.3%——
1 year+9.5%——
3-year CAGR+7.8%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
31.31M USD
Year-over-year change
+9.5%
4-year CAGR
+4.4%

Operating Expenses vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +8.0% is the 3rd highest of 8, against a peer median of -12.5%.
  • Operating expenses amounts to 31.2% of revenue for FONR, versus a peer median of 136.0%.
FONR Competitors
Operating Expenses for FONR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LUNGPulmonx CorporationLTM Mar 2026$118.9M USD-2.5%+7.0%134.3%
RCELAVITA Medical, Inc.LTM Mar 2026$98.38M USD-12.5%+21.7%136.0%
ARTVArtiva Biotherapeutics, Inc.LTM Mar 2026$91.4M USD+21.9%+10.8%—
HYPRHyperfine, Inc.LTM Mar 2026$42.59M USD-12.9%-16.3%277.8%
IFRXInflaRx N.V.LTM Mar 2026€35.14M EUR-30.5%+8.4%119798.7%
FONRFONAR CorporationLTM Mar 2026$32.88M USD+8.0%+7.8%31.2%
VANIVivani Medical, Inc.LTM Mar 2026$27.68M USD+11.1%+8.5%—
APYXApyx Medical CorporationLTM Mar 2026$22.35M USD-43.7%-21.5%40.0%
Peer median (excluding FONR) —-12.5%+8.4%136.0%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue89.93M97.59M98.65M102.88M104.35M
Cost of Revenue46.46M50.58M52.9M57.74M61.44M
Gross Profit43.47M47.01M45.75M45.14M42.91M
Gross Margin48.3%48.2%46.4%43.9%41.1%
Research & Development1.64M1.49M1.57M1.74M1.58M
Selling, General & Admin0029.39M029.73M
Operating Expenses26.38M25.01M30.96M28.6M31.31M
Depreciation & Amortization4.08M4.54M8.8M4.6M4.7M
EBITDA22M27.65M24.61M23.94M18.5M
EBITDA Margin24.5%28.3%25.0%23.3%17.7%
Operating Income17.1M22.01M14.79M16.54M11.6M
Operating Margin19.0%22.6%15.0%16.1%11.1%
Interest Income00002.17M
Interest Expense248.67K346.55K50.13K77K25.61K
Other Income / Expenses567.72K761.69K969.33K2.73M2.18M
Income Before Tax17.67M22.77M15.76M19.27M13.78M
Pre-Tax Margin19.6%23.3%16.0%18.7%13.2%
Income Tax Expense3.99M5.53M3.63M5.17M3.11M
Net Income10.21M12.44M9.38M10.57M8.33M
Net Margin11.4%12.7%9.5%10.3%8.0%
EPS (Basic)1.471.781.351.561.26
EPS (Diluted)1.451.751.321.531.23
Weighted Avg Shares6.61M6.55M6.65M6.35M6.32M
Weighted Avg Shares (Diluted)6.74M6.68M6.77M6.48M6.55M

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.